https://www.bloomtechz.com/synthetic-chemical/api-researching-only/pontocaine-cas-94-24-6.html
|
|
|
Tetracaine is usually given as an injectable solution in vials or ampoules for more invasive procedures. For procedures that necessitate extensive local numbness, such as surgical interventions or diagnostic procedures, these injectable solutions are used for deeper anesthesia. Injectable tetracaine is packaged to ensure sterility and precise dosing. Vials frequently contain specific concentrations of the anesthetic to meet the requirements of various procedures. At times, tetracaine might be pre-weakened or joined with different specialists, like epinephrine, to improve its viability and draw out its span of activity.
s
01
02
03
For products intended for ophthalmic use, maintaining sterility is paramount. Once opened, single-use containers should be used immediately and then discarded.
04
05
American Society of Health-System Pharmacists. (2021). Tetracaine. In AHFS Drug Information.
U.S. Food and Drug Administration. (2020). Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics.
World Health Organization. (2019). Guidelines on packaging for pharmaceutical products.
Rossi, S. (Ed.). (2021). Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd.
Joint Formulary Committee. (2021). British National Formulary. London: BMJ Group and Pharmaceutical Press.